All Stories

  1. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption

    Article • Transfusion, December 2014, Wiley

    Mr Andrew R Crow

  2. Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway

    Article • PLoS ONE, August 2013, PLOS

    Mr Andrew R Crow

  3. The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia

    Article • Blood, October 2011, American Society of Hematology

    Mr Andrew R Crow

  4. Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?

    Article • Blood, November 2010, American Society of Hematology

    Mr Andrew R Crow

  5. Transfusion of antibody-opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model

    Article • Transfusion, April 2010, Wiley

    Mr Andrew R Crow

  6. New insight into the mechanism of action of IVIg: the role of dendritic cells

    Article • Journal of Thrombosis and Haemostasis, July 2009, Wiley

    Mr Andrew R Crow

  7. Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

    Article • Blood, December 2008, American Society of Hematology

    Mr Andrew R Crow

  8. Transfusion of IgG-Opsonized Foreign Red Blood Cells Mediates Reduction of Antigen-Specific B Cell Priming in a Murine Model

    Article • The Journal of Immunology, July 2008, The American Association of Immunologists

    Mr Andrew R Crow

  9. Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus...

    Article • Immunology, May 2008, Wiley

    Mr Andrew R Crow

  10. The Mechanisms of Action of Intravenous Immunoglobulin and Polyclonal Anti-D Immunoglobulin in the Amelioration of Immune Thrombocytopenic Purpura: What Do We Really Know?

    Article • Transfusion Medicine Reviews, April 2008, Elsevier

    Mr Andrew R Crow

  11. IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?

    Article • British Journal of Haematology, October 2007, Wiley

    Mr Andrew R Crow

  12. A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

    Article • Blood, January 2007, American Society of Hematology

    Mr Andrew R Crow

  13. Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

    Article • Nature Reports Stem Cells, May 2006, Springer Science + Business Media

    Mr Andrew R Crow

  14. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia

    Article • Pediatric Blood & Cancer, January 2006, Wiley

    Mr Andrew R Crow

  15. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg

    Article • Blood, February 2005, American Society of Hematology

    Mr Andrew R Crow

  16. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?

    Article • Journal of Clinical Investigation, January 2005, American Society for Clinical Investigation

    Mr Andrew R Crow

  17. Role of Fc?? Receptors in the Pathogenesis and Treatment of Idiopathic Thrombocytopenic Purpura

    Article • Journal of Pediatric Hematology/Oncology, December 2003, Wolters Kluwer Health

    Mr Andrew R Crow

  18. Mechanism of action of IVIG and anti-D in ITP

    Article • Transfusion and Apheresis Science, June 2003, Elsevier

    Mr Andrew R Crow

  19. CD154 (CD40 ligand)-deficient mice exhibit prolonged bleeding time and decreased shear-induced platelet aggregates

    Article • Journal of Thrombosis and Haemostasis, April 2003, Wiley

    Mr Andrew R Crow

  20. IVIg-mediated amelioration of murine ITP via Fc RIIB is independent of SHIP1, SHP-1, and Btk activity

    Article • Blood, March 2003, American Society of Hematology

    Mr Andrew R Crow

  21. IVIG induces dose-dependent amelioration of ITP in rodent models

    Article • Blood, February 2003, American Society of Hematology

    Mr Andrew R Crow

  22. Understanding platelet function through signal transduction

    Article • Transfusion Medicine Reviews, January 2003, Elsevier

    Mr Andrew R Crow

  23. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG

    Article • Blood, December 2002, American Society of Hematology

    Mr Andrew R Crow

  24. IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity

    Article • British Journal of Haematology, December 2001, Wiley

    Mr Andrew R Crow

  25. Monoclonal antibody-mediated inhibition of the human HLA alloimmune response to platelet transfusion is antigen specific and independent of Fcγ receptor-mediated immune suppression

    Article • British Journal of Haematology, August 2000, Wiley

    Mr Andrew R Crow

  26. Inhibition of a secondary human alloimmune response via the soluble active component of CD154 (CD40L) in severe combined immune-deficient mice engrafted with human lymphocytes

    Article • Transfusion, August 1999, Wiley

    Mr Andrew R Crow

  27. Antibody-mediated inhibition of the human alloimmune response to platelet transfusion in Hu-PBL-SCID mice

    Article • British Journal of Haematology, March 1999, Wiley

    Mr Andrew R Crow

  28. Induction of a secondary human anti-HLA alloimmune response in severe combined immunodeficient mice engrafted with human lymphocytes

    Article • Transfusion, November 1997, Wiley

    Mr Andrew R Crow

  29. Altered Thymic and Peripheral T-Lymphocyte Repertoire Preceding Onset of Diabetes in NOD Mice

    Article • Diabetes, April 1991, American Diabetes Association

    Mr Andrew R Crow